UY38899A - DIACILGLYCEROL ACILTRANSFERASE 2 INHIBITOR - Google Patents

DIACILGLYCEROL ACILTRANSFERASE 2 INHIBITOR

Info

Publication number
UY38899A
UY38899A UY0001038899A UY38899A UY38899A UY 38899 A UY38899 A UY 38899A UY 0001038899 A UY0001038899 A UY 0001038899A UY 38899 A UY38899 A UY 38899A UY 38899 A UY38899 A UY 38899A
Authority
UY
Uruguay
Prior art keywords
diacilglycerol
aciltransferase
inhibitor
inhibitors
dgat2
Prior art date
Application number
UY0001038899A
Other languages
Spanish (es)
Inventor
Kentaro Futatsugi
Michelle Renee Garnsey
David James Edmonds
Kevin Jamese U Filipski
Jack Chang Hung Lee
Daniel Jonathan Smaltz
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of UY38899A publication Critical patent/UY38899A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

En la presente se describen compuestos de la Fórmula (I) (I) en donde R1, R2, R3, R4, R5, R6, R7, R8 y R9 se definen en la presente, su uso como inhibidores de diacilglicerol aciltransferasa 2 (DGAT2), composiciones farmacéuticas que contienen dichos inhibidores y el uso de dichos inhibidores para tratar, por ejemplo, NASH.Described herein are compounds of Formula (I) (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, and R9 are defined herein, their use as diacylglycerol acyltransferase 2 (DGAT2) inhibitors ), pharmaceutical compositions containing said inhibitors and the use of said inhibitors to treat, for example, NASH.

UY0001038899A 2019-09-03 2020-09-30 DIACILGLYCEROL ACILTRANSFERASE 2 INHIBITOR UY38899A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201963074123P 2019-09-03 2019-09-03
US201962911094P 2019-10-04 2019-10-04

Publications (1)

Publication Number Publication Date
UY38899A true UY38899A (en) 2021-04-30

Family

ID=76193366

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001038899A UY38899A (en) 2019-09-03 2020-09-30 DIACILGLYCEROL ACILTRANSFERASE 2 INHIBITOR

Country Status (1)

Country Link
UY (1) UY38899A (en)

Similar Documents

Publication Publication Date Title
CL2022000835A1 (en) Diacylglycerol acyltransferase 2 inhibitor
UY38076A (en) TETRAHYDROQUINAZOLINE DERIVATIVES USEFUL AS ANTI-CANCER AGENTS
CL2019001711A1 (en) Compositions and methods for inhibiting the action of arginase.
UY37795A (en) SULFONILUREAS AND SULFONILTIOUREAS USEFUL AS INHIBITORS OF NLRP3
CU24507B1 (en) DIACILGLICEROL ACILTRANSFERASE 2 INHIBITORS
CO2019003482A2 (en) Compounds derived from cyclobutane or azetidine 1,3 substituted as hematopoietic prostaglandin d synthase inhibitors
BR112017003658A2 (en) compound, mixture, methods for treating a disease and for inhibiting a glycosidase; and, pharmaceutical composition.
BR112018003026A2 (en) compositions comprising a pi3k inhibitor and an hdac inhibitor
BR112021022758A2 (en) Substituted 1-oxo-isoindoline-5-carboxamide compounds, their compositions and methods of treatment therewith
PE20151981A1 (en) ZESTE APPROVAL INHIBITOR PONTENCER
CL2017002856A1 (en) Thioether compounds as nitrification inhibitors
CO2019002692A2 (en) New derivatives of isoxazolyl ether as pam of gaba to alpha5.
CL2021001461A1 (en) trex1 modulators
CO2019004978A2 (en) Therapeutic compounds and methods to use them
CO2018010787A2 (en) Griseofulvin compound
CO2021001219A2 (en) Substituted benzimidazoles as pad4 inhibitors
AR125457A2 (en) DUAL MAGL AND FAAH INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITION
CL2020002217A1 (en) Use of alkoxypyrazoles as nitrification inhibitors
CO2022010011A2 (en) Novel amino aryl derivative useful as diacylglycerol acyltransferase 2 inhibitor and use thereof
MX2020004842A (en) Anti-infective heterocyclic compounds and uses thereof.
BR112023003744A2 (en) COMPOUND, AND, PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DIACYLGLYCEROL ACYLTRANSFERASE 2
BR112019021323A2 (en) HETEROCYCLIC INHIBITORS OF LYSINE BIOSYNTHESIS THROUGH THE DIAMINOPIMELATE ROUTE
UY38899A (en) DIACILGLYCEROL ACILTRANSFERASE 2 INHIBITOR
BR112015023280A2 (en) dihydroquinolin-2-one derivatives for use as aldosterone synthase inhibitors
BR112022006156A2 (en) DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR